CRBP — Corbus Pharmaceuticals Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Corbus Pharmaceuticals Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	85.4	97.6	59.2	20.9	149
Net Total Accounts Receivable
Net Total Receivables	2.58	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	92.1	100	60.2	23.5	153
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.32	7	5.5	4.04	2.52
Other Long Term Assets
Total Assets	102	108	66.3	28.3	156
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31.9	17	12.6	31.9	11.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	57	38.6	33.3	35.2	13.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	45.3	69.1	33	-6.9	142
Total Liabilities & Shareholders' Equity	102	108	66.3	28.3	156
Total Common Shares Outstanding